RP-A701

· Rocket Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP-A701, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy [Phase 1]

See pricing